It probably just gave ENTA some needed attention. Perhaps investors didn't know ENTA was working so close with ABBV or what the partnership arrangements were. A lot of exciting things going on with ENTA as per the conference call. A very strong relationship with ABBV, an exciting program with NVS and let's not forget their work with diseases such as MRSA.
Market Data 
Markets 
AI
